Telehealth & Virtual Care

When the Telehealth Visit Is the Marketing

When the Telehealth Visit Is the Marketing

George Padron
AI & Critical Decision Support, Digital Therapeutics, Healthcare Headlines, Telehealth & Virtual Care | Apr 29, 2026
Drug manufacturers partner with telehealth platforms to offer discounted visits that funnel patients to branded prescriptions, raising concerns for managed care formulary stewardship.
A Telehealth Firm's Data Diversion Raises Alarms

A Telehealth Firm's Data Diversion Raises Alarms

George Padron
Healthcare Headlines, Telehealth & Virtual Care | Mar 23, 2026
GuardDog Telehealth admitted to extracting patient records via interoperability networks and providing them to law firms, per a stipulated judgment with Epic Systems.
Walgreens Enters GLP-1 Telehealth, Focusing on Self-Pay Gap

Walgreens Enters GLP-1 Telehealth, Focusing on Self-Pay Gap

Sonia Reyes
AI & Critical Decision Support, Digital Therapeutics, Healthcare Headlines, Telehealth & Virtual Care, Obesity & Metabolic Health | Mar 21, 2026
Walgreens Weight Management offers virtual GLP-1 visits for $49 with no monthly fee, targeting the 80% of large employers that don't cover weight-loss drugs.
Telehealth Adoption by Mental Health Specialists Has Not Closed the Rural Access Gap

Telehealth Adoption by Mental Health Specialists Has Not Closed the Rural Access Gap

Sonia Reyes
Medicare/Medicaid Updates, Financial Assistance Programs, Healthcare Headlines, Telehealth & Virtual Care, Care Coordination | Mar 20, 2026
A Medicare cohort study finds telemedicine uptake barely improved mental health access in rural or shortage areas, pointing to the need for targeted policy reform.
White-Label Medical Groups Draw Regulatory Scrutiny in GLP-1 Telehealth Crackdown

White-Label Medical Groups Draw Regulatory Scrutiny in GLP-1 Telehealth Crackdown

George Padron
Healthcare Headlines, Policy & Legislation, Telehealth & Virtual Care, Obesity & Metabolic Health | Mar 18, 2026
A STAT News investigation finds that four medical groups are linked to 30% of FDA-warned GLP-1 telehealth companies, raising legal and patient safety concerns for payers.
Online Provider Withdraws Compounded Obesity Pill

Online Provider Withdraws Compounded Obesity Pill

George Padron
Healthcare Headlines, Telehealth & Virtual Care, Diabetes & Metabolic Diseases | Feb 8, 2026
Online telehealth provider Hims & Hers has withdrawn its compounded Wegovy pill alternative after federal regulatory scrutiny regarding unapproved absorption technology.
Load More
Only Healthcare Today Covering Clinical Healthcare, Access and Cost

Only Healthcare Today
Covering Clinical Healthcare, Access and Cost

1 Hewitt Square, Suite 139
East Northport, NY 11731

Who We Are


About Us Editorial Policy Contributors & Partners

Connect


Contact Us Work With Us Advertising Terms of Use Privacy Policy